Fig. 1 · Structure
Documents & Downloads
HBV-IN-13
HBsAg Inhibitor
HBV-IN-13 is a potent inhibitor of hepatitis B surface antigen (HBsAg), targeting the early stages of hepatitis B virus infection. This compound demonstrates significant antiviral activity, making it a valuable tool for research focused on hepatitis B virus therapies and vaccine development. hbv-inhibitors such as HBV-IN-13 can aid in the exploration of mechanisms of viral assembly and release, facilitating advancements in the understanding of chronic hepatitis B management.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 2724228-72-0 |
| Applications | HBsAg Inhibitor |
| Formula | C22H25NO7 |
| Molecular Weight | 415.44 |
| SMILES | CC([C@H]1N2C(C3=C(C1)C=C(OCCCOC)C4=C3OCO4)=CC(C(C(O)=O)=C2)=O)C |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.